Global Apomorphine Delivery Device Market Growth 2023-2029

Global Apomorphine Delivery Device Market Growth 2023-2029

Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.

LPI (LP Information)' newest research report, the “Apomorphine Delivery Device Industry Forecast” looks at past sales and reviews total world Apomorphine Delivery Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Apomorphine Delivery Device sales for 2023 through 2029. With Apomorphine Delivery Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Apomorphine Delivery Device industry.

This Insight Report provides a comprehensive analysis of the global Apomorphine Delivery Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Apomorphine Delivery Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Apomorphine Delivery Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Apomorphine Delivery Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Apomorphine Delivery Device.

The global Apomorphine Delivery Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Apomorphine Delivery Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Apomorphine Delivery Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Apomorphine Delivery Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Apomorphine Delivery Device players cover Supernus Pharmaceuticals, Britannia Pharmaceuticals STADA, Ever Pharma and Evolan Pharma AB (PharmSwed), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Apomorphine Delivery Device market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Pen Injectors
Infusion Pumps

Segmentation by application
Parkinson Disease
Erectile Dysfunction

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)

Key Questions Addressed in this Report

What is the 10-year outlook for the global Apomorphine Delivery Device market?

What factors are driving Apomorphine Delivery Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Apomorphine Delivery Device market opportunities vary by end market size?

How does Apomorphine Delivery Device break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global Apomorphine Delivery Device by Company
4 World Historic Review for Apomorphine Delivery Device by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Apomorphine Delivery Device by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings